Studies have shown that TLR2 mRNA expression in intestinal mucosal tissue is significantly higher in IBD patients compared to normal subjects, while TLR1 R80T and TLR2 R735G heterozygous carriers are at increased risk of total colitis [46]. Here, TLR2 is linked to inflammatory bowel disease.